Zobrazeno 1 - 10
of 3 585
pro vyhledávání: ''
Autor:
Thomas S. Franko
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:319-323
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:180-185
Publikováno v:
Biopharmaceutics & Drug Disposition. 42:427-434
Background To explore the clinical application of a population pharmacokinetics (PPK) model of vancomycin in patients with hematological diseases and neutropenia. Methods Patients with hematological diseases and neutropenia were included in the PPK m
Autor:
Baylie Slowik, Stephanie Seyse, Nicole E. Cieri-Hutcherson, Jennifer Abeles, Erin E. Conway‐Habes, Domenique N. Ciriello, Ashley E. Woodruff
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5:141-148
Publikováno v:
British Journal of Clinical Pharmacology. 88:1279-1287
Background: Propofol may result in hypotension, bradycardia, and loss of protective reflexes, especially in elderly patients, while esketamine, a N-methyl-D-aspartate receptor antagonists, has analgesic, anaesthetic and sympathomimetic properties and
Publikováno v:
Journal of Pharmacy Practice and Research. 51:390-395
Autor:
David G. Soergel, Kimberly A. Ramos, Ian E. James, Michael J. Fossler, Dennis Ruff, Franck Skobieranda
Publikováno v:
Clinical Pharmacology in Drug Development. 11:51-62
TRV734, an oral G-protein biased ligand at the μ-opioid receptor has demonstrated differentiated pharmacology in preclinical studies compared to unbiased ligands. First-time-in-human data suggested that TRV734 was safe and well tolerated and caused
Autor:
Joann Lee, Gerald J. Dal Pan, Esther H. Zhou, Travis Ready, Ellen Pinnow, Daniel Bak, Zhou Feng
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:1551-1559
Purpose To evaluate the impact of FDA's 2013 zolpidem Drug Safety Communications (DSCs), which recommended lowering the initial dose to mitigate drowsiness, on national estimates of zolpidem users and zolpidem exposure cases. Methods We analyzed tren
Autor:
Outi Aikio, Mikko Hallman, Saïk Urien, Jean-Christophe Rozé, Naïm Bouazza, Jean-Marc Tréluyer, Frantz Foissac
Publikováno v:
Clinical Pharmacology & Therapeutics. 110:1087-1095
In preterm infants, a high risk of hemodynamically significant patent ductus arteriosus (PDA) exists and its persistence is associated with an increased risk of severe morbidity. Current pharmacological options include ibuprofen or indomethacin. Howe
Publikováno v:
British Journal of Clinical Pharmacology. 88:587-599
Aims Pulmonary arterial hypertension (PAH) is characterized by increased pulmonary arterial pressure, resulting in right ventricular overload, right heart failure and eventually death. Treprostinil is a prostacyclin analogue that is used in the treat